Department of Clinical Biochemistry, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Breast Cancer Research Center, Motamed Cancer Institute, ACERCR, Tehran, Iran.
Biol Trace Elem Res. 2023 Jul;201(7):3233-3244. doi: 10.1007/s12011-022-03439-5. Epub 2022 Oct 12.
Breast cancer is a multifactorial disease, and among the many factors which are involved in the onset, progression, and invasion of the disease, oxidative stress plays a significant role. The concentration and activity of enzymatic antioxidants are proportional to the concentration of trace elements, and the concentration of trace elements is often deficient in malignancies. Therefore, in the present study, we studied the tissue levels of oxidative stress, antioxidant status, zinc (Zn), and copper (Cu) in breast cancer patients. Tissue samples were collected from 40 patients with breast cancer and 40 tumor margin tissue as a control group. All subjects gave their informed consent. The tissue samples were measured for superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX), total antioxidants capacity (TAC), total oxidant status (TOS), oxidative stress index (OSI), malondialdehyde (MDA), Zn, and Cu. Data of all biochemical parameters of two groups were statistically analyzed by SPSS software, t test, and GraphPad Prism. Concentrations of MDA, TOS, and OSI in tumor tissue were significantly higher than tumor margin tissue, but the level of TAC and CAT, SOD, and GPX activities was significantly reduced in tumor tissue (p<0.05). It was found that the concentrations of Zn and Cu in breast cancer patients were higher than tumor margin tissue. Patients with breast cancer have a rise in oxidative stress indicators and a decrease in antioxidant stress markers. Since oxidative stress is a significant contributor to the development and progression of breast cancer, more research might lead to a more effective method of breast cancer treatment. Considering the dual role of oxidative stress in cancer, which can both cause survival and adaptation, and the death of cancer cells, and with more information, it can be used to manage the treatment and destruction of cancer cells.
乳腺癌是一种多因素疾病,在涉及疾病发生、进展和侵袭的众多因素中,氧化应激起着重要作用。抗氧化酶的浓度和活性与微量元素的浓度成正比,而微量元素的浓度在恶性肿瘤中往往不足。因此,本研究检测了乳腺癌患者组织中的氧化应激、抗氧化状态、锌(Zn)和铜(Cu)的水平。采集了 40 例乳腺癌患者和 40 例肿瘤边缘组织的组织样本作为对照组。所有患者均签署了知情同意书。测量了组织样本中超氧化物歧化酶(SOD)、过氧化氢酶(CAT)、谷胱甘肽过氧化物酶(GPX)、总抗氧化能力(TAC)、总氧化状态(TOS)、氧化应激指数(OSI)、丙二醛(MDA)、Zn 和 Cu 的含量。使用 SPSS 软件对两组所有生化参数数据进行 t 检验和 GraphPad Prism 统计分析。肿瘤组织中 MDA、TOS 和 OSI 的浓度明显高于肿瘤边缘组织,而 TAC 和 CAT、SOD 和 GPX 活性水平明显降低(p<0.05)。发现乳腺癌患者的 Zn 和 Cu 浓度高于肿瘤边缘组织。乳腺癌患者的氧化应激指标升高,抗氧化应激标志物降低。由于氧化应激是乳腺癌发生和进展的重要原因,因此进一步的研究可能会导致更有效的乳腺癌治疗方法。考虑到氧化应激在癌症中的双重作用,它既能导致癌细胞的生存和适应,又能导致癌细胞的死亡,并且随着更多的信息,可以用于管理癌症细胞的治疗和破坏。